04:28 PM EDT, 03/28/2025 (MT Newswires) -- Pactiv Evergreen ( PTVE ) said late Friday that Novolex's proposed acquisition of the company for $18 per share in cash has received all required regulatory approvals.

The deal is now expected to close on Tuesday, the company said.

Pactiv said that upon completion of the deal, it will become a privately held company, and its shares will no longer be listed on Nasdaq.